Back
Apellis Pharmaceuticals Vs. Scholar Rock Holding Industry Stock Comparison
Buy
51
APLS
Apellis Pharmaceuticals
Last Price:
32.62
Seasonality Move:
15.03%
Buy
100
SRRK
Scholar Rock Holding
Last Price:
37.04
Seasonality Move:
10.12%
Buy
51
Apellis Pharmaceuticals (APLS)
is a Buy
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $31.91. The Score for APLS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
100
Scholar Rock Holding (SRRK)
is a Buy
Is Scholar Rock Holding a Buy, Sell or Hold?
- The current Scholar Rock Holding [SRRK] share price is $37.72. The Score for SRRK is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
- SRRK is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $31.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight selling pressure.
SRRK Stock Price Chart
What is Scholar Rock Holding's stock price today?
-
The Scholar Rock Holding share price today is $37.72
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRRK is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 62.71 | Buy |
| Chaikin Money Flow: | -1029134 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.89 - 29.53) | Buy |
| Bollinger Bands (100): | (28.51 - 38.57) | Sell |
SRRK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.83 | Buy |
| Relative Strength Index (14 RSI): | 74.99 | Buy |
| Chaikin Money Flow: | -5009875 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.64 - 31.02) | Buy |
| Bollinger Bands (100): | (6.08 - 25.5) | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.43 | Buy |
| 20-day SMA: | 28.45 | Buy |
| 50-day SMA: | 28.99 | Buy |
| 200-day SMA: | 42.18 | Sell |
| 8-day EMA: | 29.25 | Buy |
| 20-day EMA: | 28.68 | Buy |
| 50-day EMA: | 29.96 | Buy |
| 200-day EMA: | 39.38 | Sell |
SRRK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.8 | Buy |
| 20-day SMA: | 28.71 | Buy |
| 50-day SMA: | 22.69 | Buy |
| 200-day SMA: | 14.55 | Buy |
| 8-day EMA: | 30.11 | Buy |
| 20-day EMA: | 28.43 | Buy |
| 50-day EMA: | 23.91 | Buy |
| 200-day EMA: | 15.95 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.77 per share, and an increase next year of $0.81 per share.
Scholar Rock Holding Earnings Growth & SRRK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.56 per share, and an increase next year of $0.25 per share.
Apellis Pharmaceuticals Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Scholar Rock Holding Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||